Jump to content

Streptomyces clavuligerus

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rich Farmbrough (talk | contribs) at 07:30, 2 February 2011 (Simplify links and/or other minor fixes using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Streptomyces clavuligerus
Scientific classification
Kingdom:
Phylum:
Order:
Family:
Genus:
Species:
S. clavuligerus
Binomial name
Streptomyces clavuligerus
Higgens & Kastner 1971

Streptomyces clavuligerus is a species of Gram-positive bacterium that produces clavulanic acid.[1]

S. clavuligerus ATCC 27064 (NRRL 3585, DSM 738) was first described by Higgens and Kastner who isolated it from a South American soil sample.[2] Its name refers to the shape of its spore-bearing hyphal branches: clavula in Latin means little club and the suffix -igerus means bearing. S. clavuligerus spores are gray to grayish green.[2]

S. clavuligerus produces over 20 secondary metabolites, including many beta-lactam antibiotics such as clavulanic acid, cephamycin C, deacetoxycephalosporin C, penicillin N (an intermediate in cephamycin C pathway) and at least four other clavams.[3][4] Non-β-lactam antibiotics include holomycin and an antibiotic complex, MM 19290, related to tunicamycin;[5] a beta-lactamase-inhibitory protein (BLIP) has also been described.[6]

Another important characteristic of S. clavuligerus is that it is not able to use glucose as a carbon source, because it lacks a glucose transport system.[7][8]

It also possesses all the enzymes of the urea cycle, which is unusual for a prokaryote, although it is not clear if the urea cycle is functional.[9]

References

  1. ^ Reading C, Cole M (1977). "Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus". Antimicrob Agents Chemother. 11 (5): 852–7. PMC 352086. PMID 879738.
  2. ^ a b Higgens CE, Kastner RE (1971). "Streptomyces clavuligerus sp. nov., a beta-lactam antibiotic producer". International Journal of Systematic Bacteriology. 21: 326–31. doi:10.1099/00207713-21-4-326.
  3. ^ Nabais AMA, Dafonseca MMR (1995). "The Effect of Solid Medium Composition on Growth and Sporulation of Streptomyces-Clavuligerus - Spore Viability During Storage at +4-Degrees-C". Biotechnology Techniques. 9: 361–4. doi:10.1007/BF00638871.
  4. ^ Tahlan K, Anders C, Jensen S (2004). "The paralogous pairs of genes involved in clavulanic acid and clavam metabolite biosynthesis are differently regulated in Streptomyces clavuligerus". J Bacteriol. 186 (18): 6286–97. doi:10.1128/JB.186.18.6286-6297.2004. PMC 515150. PMID 15342599.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ Baggaley K, Brown A, Schofield C (1997). "Chemistry and biosynthesis of clavulanic acid and other clavams". Nat Prod Rep. 14 (4): 309–33. doi:10.1039/np9971400309. PMID 9281835.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. ^ Doran J, Leskiw B, Aippersbach S, Jensen S (1990). "Isolation and characterization of a beta-lactamase-inhibitory protein from Streptomyces clavuligerus and cloning and analysis of the corresponding gene". J Bacteriol. 172 (9): 4909–18. PMC 213145. PMID 2203736.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ^ Aharonowitz Y, Demain A (1 August 1978). "Carbon catabolite regulation of cephalosporin production in Streptomyces clavuligerus". Antimicrob Agents Chemother. 14 (2): 159–64. PMC 352426. PMID 697343.
  8. ^ Garcia-Dominguez M, Martin J, Liras P (1989). "Characterization of sugar uptake in wild-type Streptomyces clavuligerus, which is impaired in glucose uptake, and in a glucose-utilizing mutant". J Bacteriol. 171 (12): 6808–14. PMC 210580. PMID 2687256.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. ^ Kirk S (2000). "The physiology of clavulanic acid production by Streptomyces clavuligerus (PhD thesis)". University of Surrey, UK. {{cite journal}}: Cite journal requires |journal= (help)